Denovai
Rehovot, IL · 1 known investors
DenovAI Biotech uses artificial intelligence and computational molecular biophysics to design proteins de novo, building platforms for rapid antibody discovery and bespoke high-affinity binders. The company targets therapeutic and diagnostic applications, including antibodies, peptide biologics, and diagnostic reporters for drug discovery.
Investors · 1
Frequently asked questions
- What does Denovai do?
- DenovAI Biotech uses artificial intelligence and computational molecular biophysics to design proteins de novo, building platforms for rapid antibody discovery and bespoke high-affinity binders. The company targets therapeutic and diagnostic applications, including antibodies, peptide biologics, and diagnostic reporters for drug discovery.
- Who are Denovai's investors?
- Denovai's investors include Amiti Ventures.
- Where is Denovai headquartered?
- Denovai is headquartered in Rehovot, IL.